Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biometrics company supporting the development of new therapeutics and personalised medicine solutions, recently attended the American Conference on Pharmacometrics (ACoP) 2025 (18-21 October) – one of the key gatherings for those shaping the future of quantitative drug development – for the first time in a number of years. Dr Mark Davies, Head of Quantitative Pharmacology...
Read More